To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of funding for Abbot-Diabetes monitors; and if his Department will extend the availability of free Abbot-Diabetes monitors.
Within its financial constraint, the National Health Service is committed to providing access to new drugs and medical technologies. Ultimately it is for clinical commissioning groups (CCGs), who are primarily responsible for commissioning diabetes services, to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines.
Freestyle Libre, the flash glucose monitoring system manufactured by Abbot was included in Part IX of the England and Wales Drug Tariff from November 2017. People with diabetes insipidus or diabetes mellitus (except where treatment is by diet alone) - which includes type 1 and type 2 diabetes - are eligible for free NHS prescriptions if they hold a valid medical exemption certificate. However, patients will need to discuss the ongoing management of their condition with their healthcare professional and consider what is most suitable for them.